Abstract
P59 Antitumor response of preclinical tumor models to IGF-IR targeted therapy is not dependent on PTEN or PIK3CA mutational status
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/s1096-6374(10)70159-3
Journal: Growth Hormone & IGF Research | Publication Date: Jan 1, 2010 |
P59 Antitumor response of preclinical tumor models to IGF-IR targeted therapy is not dependent on PTEN or PIK3CA mutational status
Join us for a 30 min session where you can share your feedback and ask us any queries you have